Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation "POPular-TAVI"


Phase 4 Results N/A

Summary of Purpose

At present, a variety of antithrombotic regimens are prescribed in the early postprocedure period after transcatheter aortic valve implantation (TAVI). Dual antiplatelet therapy (DAPT) using aspirin and a thienopyridine in the initial period after TAVI is the recommended strategy; however, mono antiplatelet therapy using aspirin is suggested not to be inferior. In patients with atrial fibrillation (AF) or another...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 February 2018.

1 Jan 2014 19 Sep 2014 1 Dec 2018 1 Dec 2019 1 Feb 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Intervention: Parallel Assignment